MedPath

PEMETREXED SWANPOND INVESTMENTS 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

PEMETREXED SWANPOND INVESTMENTS 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Pending
Register Number

81942

Prescription Type

Uso Hospitalario

Authorization Date

Apr 6, 2017

Dosage Form

POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number81942
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

PEMETREXEDActive
Quantity: 100 mg
Name: PEMETREXED

ATC CLASSIFICATION (3)

L01B
L01BA
L01BA04

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.